continuous glucose monitor data Search Results


90
Abbott Laboratories continuous glucose monitoring (cgm) freestyle libre 2
Continuous Glucose Monitoring (Cgm) Freestyle Libre 2, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous glucose monitoring (cgm) freestyle libre 2/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
continuous glucose monitoring (cgm) freestyle libre 2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
RenderX Inc regulated devices like wearable continuous glucose monitors
Regulated Devices Like Wearable Continuous Glucose Monitors, supplied by RenderX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/regulated devices like wearable continuous glucose monitors/product/RenderX Inc
Average 90 stars, based on 1 article reviews
regulated devices like wearable continuous glucose monitors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MiniMed Inc continuous glucose monitor system (cgms
Continuous Glucose Monitor System (Cgms, supplied by MiniMed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous glucose monitor system (cgms/product/MiniMed Inc
Average 90 stars, based on 1 article reviews
continuous glucose monitor system (cgms - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Senseonics continuous blood glucose monitoring system
Continuous Blood Glucose Monitoring System, supplied by Senseonics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous blood glucose monitoring system/product/Senseonics
Average 90 stars, based on 1 article reviews
continuous blood glucose monitoring system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc g4® platinum glucose sensor transmitter
G4® Platinum Glucose Sensor Transmitter, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g4® platinum glucose sensor transmitter/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g4® platinum glucose sensor transmitter - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
International Federation of Clinical Chemistry and Laboratory Medicine cgm device
Cgm Device, supplied by International Federation of Clinical Chemistry and Laboratory Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgm device/product/International Federation of Clinical Chemistry and Laboratory Medicine
Average 90 stars, based on 1 article reviews
cgm device - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc continuous glucose monitoring
Continuous Glucose Monitoring, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous glucose monitoring/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
continuous glucose monitoring - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Meiqi Trading Co continuous glucose monitor (cgm) device
(A) Flow diagram of study design and participating patients. (B) Changes of daily insulin dose. Data of the same subject at different follow‐up time points are connected by gray lines. False discovery rate (represented as q ‐value) was calculated using repeated‐measures one‐way analysis of variance corrected by Benjamini and Hochberg method for multiple comparisons, n = 14. (C) Postprandial glucose excursions expressed as percentage of baseline during steamed bun meal test (SBMT). All data are represented as mean ± SEM, * q < 0.05 by mixed‐effects model for repeated measures corrected by Benjamini and Hochberg method, n = 9–12. (D–H) Changes of glycemic variability (GV) indices at 1 week (T1W) calculated using continuous glucose monitor <t>(CGM)</t> data: (D) MAGE, (E) SDBG, (F) BG > 11.1 mmol/L, (G) LAGE, and (H) MBG. † p < .05 by paired t test (two‐tailed), n = 14. (I–J) Changes of GV indices at T1W, 1 month (T1M), and 3 months (T3M) calculated using self‐monitoring of blood glucose data: (I) TIR and (J) hypoglycemic episodes. $ q < 0.05 as stated in (B); # q < 0.05 by repeated‐measures Friedman test corrected by Benjamini and Hochberg method, n = 14. (K) Representative CGM 24‐h glucose profiles demonstrating improved glycemic stability in two patients <t>by</t> <t>WMT.</t> Values of some GV indices were the same for different participants. Thus, both points and connecting lines overlapped with each other, exhibiting fewer than 14 points. LAGE, largest amplitude of glycemic excursions; MAGE, mean amplitude of glycemic excursion; MBG, mean blood glucose; SDBG, SD of blood glucose; TIR, time in range; WMT, washed microbiota transplantation.
Continuous Glucose Monitor (Cgm) Device, supplied by Meiqi Trading Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous glucose monitor (cgm) device/product/Meiqi Trading Co
Average 90 stars, based on 1 article reviews
continuous glucose monitor (cgm) device - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc continuous glucose monitoring data
(A) Flow diagram of study design and participating patients. (B) Changes of daily insulin dose. Data of the same subject at different follow‐up time points are connected by gray lines. False discovery rate (represented as q ‐value) was calculated using repeated‐measures one‐way analysis of variance corrected by Benjamini and Hochberg method for multiple comparisons, n = 14. (C) Postprandial glucose excursions expressed as percentage of baseline during steamed bun meal test (SBMT). All data are represented as mean ± SEM, * q < 0.05 by mixed‐effects model for repeated measures corrected by Benjamini and Hochberg method, n = 9–12. (D–H) Changes of glycemic variability (GV) indices at 1 week (T1W) calculated using continuous glucose monitor <t>(CGM)</t> data: (D) MAGE, (E) SDBG, (F) BG > 11.1 mmol/L, (G) LAGE, and (H) MBG. † p < .05 by paired t test (two‐tailed), n = 14. (I–J) Changes of GV indices at T1W, 1 month (T1M), and 3 months (T3M) calculated using self‐monitoring of blood glucose data: (I) TIR and (J) hypoglycemic episodes. $ q < 0.05 as stated in (B); # q < 0.05 by repeated‐measures Friedman test corrected by Benjamini and Hochberg method, n = 14. (K) Representative CGM 24‐h glucose profiles demonstrating improved glycemic stability in two patients <t>by</t> <t>WMT.</t> Values of some GV indices were the same for different participants. Thus, both points and connecting lines overlapped with each other, exhibiting fewer than 14 points. LAGE, largest amplitude of glycemic excursions; MAGE, mean amplitude of glycemic excursion; MBG, mean blood glucose; SDBG, SD of blood glucose; TIR, time in range; WMT, washed microbiota transplantation.
Continuous Glucose Monitoring Data, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous glucose monitoring data/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
continuous glucose monitoring data - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GlySure Ltd intravascular system
(A) Flow diagram of study design and participating patients. (B) Changes of daily insulin dose. Data of the same subject at different follow‐up time points are connected by gray lines. False discovery rate (represented as q ‐value) was calculated using repeated‐measures one‐way analysis of variance corrected by Benjamini and Hochberg method for multiple comparisons, n = 14. (C) Postprandial glucose excursions expressed as percentage of baseline during steamed bun meal test (SBMT). All data are represented as mean ± SEM, * q < 0.05 by mixed‐effects model for repeated measures corrected by Benjamini and Hochberg method, n = 9–12. (D–H) Changes of glycemic variability (GV) indices at 1 week (T1W) calculated using continuous glucose monitor <t>(CGM)</t> data: (D) MAGE, (E) SDBG, (F) BG > 11.1 mmol/L, (G) LAGE, and (H) MBG. † p < .05 by paired t test (two‐tailed), n = 14. (I–J) Changes of GV indices at T1W, 1 month (T1M), and 3 months (T3M) calculated using self‐monitoring of blood glucose data: (I) TIR and (J) hypoglycemic episodes. $ q < 0.05 as stated in (B); # q < 0.05 by repeated‐measures Friedman test corrected by Benjamini and Hochberg method, n = 14. (K) Representative CGM 24‐h glucose profiles demonstrating improved glycemic stability in two patients <t>by</t> <t>WMT.</t> Values of some GV indices were the same for different participants. Thus, both points and connecting lines overlapped with each other, exhibiting fewer than 14 points. LAGE, largest amplitude of glycemic excursions; MAGE, mean amplitude of glycemic excursion; MBG, mean blood glucose; SDBG, SD of blood glucose; TIR, time in range; WMT, washed microbiota transplantation.
Intravascular System, supplied by GlySure Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/intravascular system/product/GlySure Ltd
Average 90 stars, based on 1 article reviews
intravascular system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Abbott Laboratories transcutaneous sensor freestyle navigator
Summary of Interstitial Glucose versus Blood Glucose Average Lag Time, Estimated Values and Related Study Information
Transcutaneous Sensor Freestyle Navigator, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transcutaneous sensor freestyle navigator/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
transcutaneous sensor freestyle navigator - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MiniMed Inc minilinktm real-time transmitter continuous glucose monitoring system (rt-cgms)
Summary of Interstitial Glucose versus Blood Glucose Average Lag Time, Estimated Values and Related Study Information
Minilinktm Real Time Transmitter Continuous Glucose Monitoring System (Rt Cgms), supplied by MiniMed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/minilinktm real-time transmitter continuous glucose monitoring system (rt-cgms)/product/MiniMed Inc
Average 90 stars, based on 1 article reviews
minilinktm real-time transmitter continuous glucose monitoring system (rt-cgms) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) Flow diagram of study design and participating patients. (B) Changes of daily insulin dose. Data of the same subject at different follow‐up time points are connected by gray lines. False discovery rate (represented as q ‐value) was calculated using repeated‐measures one‐way analysis of variance corrected by Benjamini and Hochberg method for multiple comparisons, n = 14. (C) Postprandial glucose excursions expressed as percentage of baseline during steamed bun meal test (SBMT). All data are represented as mean ± SEM, * q < 0.05 by mixed‐effects model for repeated measures corrected by Benjamini and Hochberg method, n = 9–12. (D–H) Changes of glycemic variability (GV) indices at 1 week (T1W) calculated using continuous glucose monitor (CGM) data: (D) MAGE, (E) SDBG, (F) BG > 11.1 mmol/L, (G) LAGE, and (H) MBG. † p < .05 by paired t test (two‐tailed), n = 14. (I–J) Changes of GV indices at T1W, 1 month (T1M), and 3 months (T3M) calculated using self‐monitoring of blood glucose data: (I) TIR and (J) hypoglycemic episodes. $ q < 0.05 as stated in (B); # q < 0.05 by repeated‐measures Friedman test corrected by Benjamini and Hochberg method, n = 14. (K) Representative CGM 24‐h glucose profiles demonstrating improved glycemic stability in two patients by WMT. Values of some GV indices were the same for different participants. Thus, both points and connecting lines overlapped with each other, exhibiting fewer than 14 points. LAGE, largest amplitude of glycemic excursions; MAGE, mean amplitude of glycemic excursion; MBG, mean blood glucose; SDBG, SD of blood glucose; TIR, time in range; WMT, washed microbiota transplantation.

Journal: Journal of Diabetes

Article Title: Washed microbiota transplantation reduces glycemic variability in unstable diabetes

doi: 10.1111/1753-0407.13485

Figure Lengend Snippet: (A) Flow diagram of study design and participating patients. (B) Changes of daily insulin dose. Data of the same subject at different follow‐up time points are connected by gray lines. False discovery rate (represented as q ‐value) was calculated using repeated‐measures one‐way analysis of variance corrected by Benjamini and Hochberg method for multiple comparisons, n = 14. (C) Postprandial glucose excursions expressed as percentage of baseline during steamed bun meal test (SBMT). All data are represented as mean ± SEM, * q < 0.05 by mixed‐effects model for repeated measures corrected by Benjamini and Hochberg method, n = 9–12. (D–H) Changes of glycemic variability (GV) indices at 1 week (T1W) calculated using continuous glucose monitor (CGM) data: (D) MAGE, (E) SDBG, (F) BG > 11.1 mmol/L, (G) LAGE, and (H) MBG. † p < .05 by paired t test (two‐tailed), n = 14. (I–J) Changes of GV indices at T1W, 1 month (T1M), and 3 months (T3M) calculated using self‐monitoring of blood glucose data: (I) TIR and (J) hypoglycemic episodes. $ q < 0.05 as stated in (B); # q < 0.05 by repeated‐measures Friedman test corrected by Benjamini and Hochberg method, n = 14. (K) Representative CGM 24‐h glucose profiles demonstrating improved glycemic stability in two patients by WMT. Values of some GV indices were the same for different participants. Thus, both points and connecting lines overlapped with each other, exhibiting fewer than 14 points. LAGE, largest amplitude of glycemic excursions; MAGE, mean amplitude of glycemic excursion; MBG, mean blood glucose; SDBG, SD of blood glucose; TIR, time in range; WMT, washed microbiota transplantation.

Article Snippet: Three days before WMT, patients were implanted with a continuous glucose monitor (CGM) device (MeiQi Medical Instruments Co., Ltd., Huzhou, China).

Techniques: Two Tailed Test, Transplantation Assay

Washed microbiota transplantation (WMT) alters profiles of serum metabolites. (A) Heatmap showing changes of serum metabolites determined by non‐targeted metabolomics, n = 11–14. (B) Heatmap of Spearman's correlation coefficients between serum metabolites and glycemic variability (GV) indices. (C) The 8 positively correlated metabolites between fecal and serum compartments. Color range varies from light red (weaker correlation) to dark red (stronger correlation). Statistical methods were the same as stated in Figure . AUC, area under the curve; BG, blood glucose; CGM, continuous glucose monitor; CV, coefficient of variation; HbA1c, glycated hemoglobin; LAGE, largest amplitude of glycemic excursions; MBG, mean blood glucose; PPGE, postprandial glucose excursion; SBMT, steamed bun meal test; SMBG, self‐monitoring of blood glucose; TIR, time in range.

Journal: Journal of Diabetes

Article Title: Washed microbiota transplantation reduces glycemic variability in unstable diabetes

doi: 10.1111/1753-0407.13485

Figure Lengend Snippet: Washed microbiota transplantation (WMT) alters profiles of serum metabolites. (A) Heatmap showing changes of serum metabolites determined by non‐targeted metabolomics, n = 11–14. (B) Heatmap of Spearman's correlation coefficients between serum metabolites and glycemic variability (GV) indices. (C) The 8 positively correlated metabolites between fecal and serum compartments. Color range varies from light red (weaker correlation) to dark red (stronger correlation). Statistical methods were the same as stated in Figure . AUC, area under the curve; BG, blood glucose; CGM, continuous glucose monitor; CV, coefficient of variation; HbA1c, glycated hemoglobin; LAGE, largest amplitude of glycemic excursions; MBG, mean blood glucose; PPGE, postprandial glucose excursion; SBMT, steamed bun meal test; SMBG, self‐monitoring of blood glucose; TIR, time in range.

Article Snippet: Three days before WMT, patients were implanted with a continuous glucose monitor (CGM) device (MeiQi Medical Instruments Co., Ltd., Huzhou, China).

Techniques: Transplantation Assay

Summary of Interstitial Glucose versus Blood Glucose Average Lag Time, Estimated Values and Related Study Information

Journal: European Endocrinology

Article Title: Interstitium versus Blood Equilibrium in Glucose Concentration and its Impact on Subcutaneous Continuous Glucose Monitoring Systems

doi: 10.17925/EE.2014.10.01.36

Figure Lengend Snippet: Summary of Interstitial Glucose versus Blood Glucose Average Lag Time, Estimated Values and Related Study Information

Article Snippet: Feldman B, 2003 146 , 5 , People with type 1 diabetes (n=30) , Transcutaneous sensor , FreeStyle Navigator (Abbott).

Techniques: Sampling